Optimal pandemic influenza vaccine allocation strategies for the Canadian population

PLoS Currents

Volumn , Issue JAN, 2010, Pages

  Tuite, Ashleigh ^d   Fisman, David N ^a   Kwong, Jeffrey C ^b   Greer, Amy ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955715962     PISSN: None     EISSN: 21573999     Source Type: Journal    
DOI: 10.1371/currents.RRN1144     Document Type: Article

References (39)

1. Chan M World now at the start of 2009 influenza pandemic (June 11, 2009). Retrieved 26 Jul 2009, from http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/.
2. National Advisory Committee on Immunization (2008) Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS). Can Commun Dis Rep 34: 1-46.
3. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E (2007) Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 357: 1373-1381.
4. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA (2007) Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 7: 658-666.
5. Goodwin K, Viboud C, Simonsen L (2006) Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24: 1159-1169.
6. Galvani AP, Reluga TC, Chapman GB (2007) Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum. Proc Natl Acad Sci U S A 104: 5692-5697.
7. Negri E, Colombo C, Giordano L, Groth N, Apolone G, et al. (2005) Influenza vaccine in healthy children: a meta-analysis. Vaccine 23: 2851-2861.
8. Smith S, Demicheli V, Di Pietrantonj C, Harnden AR, Jefferson T, et al. (2006) Vaccines for preventing influenza in healthy children. Cochrane Db Syst Rev (Online) 1: CD004879.
9. Manzoli L, Schioppa F, Boccia A, Villari P (2007) The efficacy of influenza vaccine for healthy children: a metaanalysis evaluating potential sources of variation in efficacy estimates including study quality. Pediatr Infect Dis J 26: 97-106.
10. Ahmed R, Oldstone MB, Palese P (2007) Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic. Nat Immunol 8: 1188-1193.
11. Miller MA, Viboud C, Balinska M, Simonsen L (2009) The signature features of influenza pandemics--implications for policy. N Engl J Med.
12. Fisman DN, Savage R, Gubbay J, Achonu C, Akwar H, et al. (2009) Older age and a reduced likelihood of 2009 H1N1 virus infection. N Engl J Med 361: 2000-2001.
13. Miller MA, Viboud C, Olson DR, Grais RF, Rabaa MA, et al. (2008) Prioritization of influenza pandemic vaccination to minimize years of life lost. J Infect Dis 198: 305-311.
14. Fraser C, Riley S, Anderson RM, Ferguson NM (2004) Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci U S A 101: 6146-6151.
15. Statistics Canada. Age and sex highlight tables, 2006 Census, catalogue number 97-551-XWE2006002, released 17 Jul 2007.
16. Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, et al. (2009) Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 361: 674-679.
17. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360: 2605-2615.
18. Mossong J, Hens N, Jit M, Beutels P, Auranen K, et al. (2008) Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 5: e74.
19. Statistics Canada. Pregnancy outcomes by age group (live births). Retrieved 21 Aug 2009, from http://www40.statcan.gc.ca/l01/cst01/hlth65b-eng.htm.
20. Statistics Canada. Pregnancy outcomes by age group (total pregnancies). Retrieved 21 Aug 2009, from http://www40.statcan.gc.ca/l01/cst01/hlth65a-eng.htm.
21. Bansal S, Pourbohloul B, Meyers LA (2006) A comparative analysis of influenza vaccination programs. PLoS Med 3: e387.
22. Tuite AR, Greer AL, Whelan M, Winter AL, Lee B, et al. (2009) Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza. CMAJ.
23. (2009) Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 58: 521-524.
24. Wilson N, Baker MG (2009) The emerging influenza pandemic: estimating the case fatality ratio. Euro Surveill 14.
25. Beland Y (2002) Canadian community health survey--methodological overview. Health Rep 13: 9-14.
26. Kwong JC, Stukel TA, Lim J, McGeer AJ, Upshur RE, et al. (2008) The effect of universal influenza immunization on mortality and health care use. PLoS Med 5: e211.
27. Bingle CL, Holowaty PH, Koren IE, Picard L, Stewart PJ, et al. (2005) An evaluation of the Ontario Rapid Risk Factor Surveillance System. Can J Public Health 96: 145-150.
28. Public Health Agency of Canada Guidance on H1N1 flu vaccine sequencing. Retrieved 3 Nov 2009, from http://www.phac-aspc.gc.ca/alert-alerte/h1n1/vacc/vacc-eng.php.
29. Clark TW, Pareek M, Hoschler K, Dillon H, Nicholson KG, et al. (2009) Trial of influenza A (H1N1) 2009 monovalent MF59-adjuvanted vaccine--preliminary report. N Engl J Med.
30. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, et al. (2009) Response after one dose of a monovalent influenza A (H1N1) 2009 vaccine--preliminary report. N Engl J Med.
31. Henderson DA, Courtney B, Inglesby TV, Toner E, Nuzzo JB (2009) Public health and medical responses to the 1957-58 influenza pandemic. Biosecur Bioterror.
32. Medlock J, Galvani AP (2009) Optimizing influenza vaccine distribution. Science 325: 1705-1708.
33. Simonsen L, Reichert TA, Viboud C, Blackwelder WC, Taylor RJ, et al. (2005) Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 165: 265-272.
34. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, et al. (2009) Pandemic potential of a strain of influenza A (H1N1): early findings. Science 324: 1557-1561.
35. Pourbohloul B, Ahued A, Davoudi B, Meza R, Meyers LA, et al. (2009) Initial human transmission dynamics of the pandemic (H1N1) 2009 virus in North America. Influenza Other Respi Viruses 3: 215-222.
36. Mills CE, Robins JM, Lipsitch M (2004) Transmissibility of 1918 pandemic influenza. Nature 432: 904-906.
37. Viboud C, Bjornstad ON, Smith DL, Simonsen L, Miller MA, et al. (2006) Synchrony, waves, and spatial hierarchies in the spread of influenza. Science 312: 447-451.
38. Uphoff H, Geis S, Gruber A, Hauri A (2009) What will the next influenza season bring about: seasonal influenza or the new A(H1N1)v? An analysis of German influenza surveillance data. Euro Surveill 14.
39. Kelly H, Grant K (2009) Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill 14.